Paul Morin, PhD was trained as a protein biophysicist, and he has 25 years’ experience guiding protein drug projects from inception through early research to FDA IND-submission handoff. His specialty skills include protein design, protein expression and purification, CMC stability and optimization, molecular biology and specialty protein conjugation methods. Three of the biologics programs he spearheaded led to human clinical studies.
Former Scientific Director and Research Fellow in Protein Science Molecular Drug Technologies, Bristol Myers Squibb